anticancer

• 抗癌性の、抗癌の、抗がんの、制癌性の

関

anti-tumor、anticarcinogenic、antitumor

　

WordNet

1. used in the treatment of cancer; "anticancer drug"; "an antineoplastic effect" (同)antineoplastic, antitumor, antitumour

Wikipedia preview

出典(authority):フリー百科事典『ウィキペディア（Wikipedia）』「2015/11/30 22:33:19」(JST)

wiki en

[Wiki en表示]

An anticarcinogen (also known as a carcinopreventive agent) is a substance that counteracts the effects of a carcinogen or inhibits the development of cancer. Anticarcinogens are different from anticarcinoma agents (also known as anticancer or anti-neoplastic agents) in that anticarcinoma agents are used to selectively destroy or inhibit cancer cells after cancer has developed. Interest in anticarcinogens is motivated primarily by the principle that it is preferable to prevent disease (preventive medicine) than to have to treat it (rescue medicine).

In theory, anticarcinogens may act via different mechanisms including enhancement of natural defences against cancer, deactivation of carcinogens, and blocking the mechanisms by which carcinogens act (such as free radical damage to DNA). Confirmation that a substance possesses anticarcinogenic activity requires extensive in vitro, in vivo, and clinical investigation. Health claims for anticarcinogens are regulated by various national and international organizations like the US Food and Drug Administration (FDA) and European Food Safety Authority (EFSA).

Substances for which an anticarcinogenic health claim is approved

When consumed as part of a low fat diet, fiber-containing grain products, fruits, and vegetables may reduce the risk of some types of cancer. Cancer is, however, a disease associated with many factors, and the nature of the relationship between fiber, fruit, and vegetable intake and decreased cancer risk is not clear.

See also

• Mutagen
• Carcinogenesis

References

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

• 1. 抗癌剤および放射線療法による卵巣機能不全 ovarian failure due to anticancer drugs and radiation
• 2. 末期進行癌における生存期間の推定 survival estimates in advanced terminal cancer
• 3. 抗レトロウイルス剤投与患者における悪性腫瘍に対する全身療法 systemic therapy for malignancy in patients on anti retroviral medications
• 4. 生物学的製剤を用いた癌治療の神経学的合併症 neurologic complications of cancer treatment with biologic agents
• 5. 癌患者における経口栄養補給および経口／経腸栄養補給の役割 the role of parenteral and enteral oral nutritional support in patients with cancer

English Journal

• Precise periodic components estimation for chronobiological signals through Bayesian Inference with sparsity enforcing prior.

• Dumitru M1, Mohammad-Djafari A2, Sain SB3.
• EURASIP journal on bioinformatics & systems biology.EURASIP J Bioinform Syst Biol.2016 Jan 20;2016(1):3. eCollection 2016.
• The toxicity and efficacy of more than 30 anticancer agents present very high variations, depending on the dosing time. Therefore, the biologists studying the circadian rhythm require a very precise method for estimating the periodic component (PC) vector of chronobiological signals. Moreover, in re
• PMID 26834783

• Plant-Mediated Synthesis of Silver Nanoparticles: Their Characteristic Properties and Therapeutic Applications.

• Chung IM1, Park I2, Seung-Hyun K1, Thiruvengadam M1, Rajakumar G3.
• Nanoscale research letters.Nanoscale Res Lett.2016 Dec;11(1):40. doi: 10.1186/s11671-016-1257-4. Epub 2016 Jan 28.
• Interest in "green nanotechnology" in nanoparticle biosynthesis is growing among researchers. Nanotechnologies, due to their physicochemical and biological properties, have applications in diverse fields, including drug delivery, sensors, optoelectronics, and magnetic devices. This review focuses on
• PMID 26821160

• Gallic Acid Ameliorates Cyclophosphamide-Induced Neurotoxicity in Wistar Rats Through Free Radical Scavenging Activity and Improvement in Antioxidant Defense System.

• Oyagbemi AA1, Omobowale TO2, Saba AB1, Olowu ER1, Dada RO1, Akinrinde AS1.
• Journal of dietary supplements.J Diet Suppl.2016 Jul 3;13(4):402-19. doi: 10.3109/19390211.2015.1103827. Epub 2015 Dec 30.
• Cyclophosphamide (CPA) is a widely used anticancer chemotherapeutic agent and its toxicity has been associated with its toxic metabolites phosphormide mustard. Therefore, the ameliorative effect of Gallic acid against neurotoxicity was examined in this study. Sixty rats were grouped into 10 rats per
• PMID 26716793

Related Links

• AntiCancer, Inc.

PDOX, PDX, Patient-Derived Xenografts, personalized cancer treatment, how to find the best cancer drugs ... THE MOST CLINICALLY-RELEVANT MODELS OF CANCER CONTRACT RESEARCH SERVICES: WHAT CAN WE DO ...

• がん細胞可視化研究のAntiCancer Japan株式会社｜アンチ ...

AntiCancer Japan株式会社のTOPページです。GFP/RFP蛍光タンパク質発現がん細胞をはじめとするin vivo蛍光イメージング技術で医療に貢献します。 ... 蛍光タンパク質(GFP/RFP)発現がん細胞 蛍光タンパク質遺伝子を導入した70種類以上の ...

Related Pictures

---

★リンクテーブル★

リンク元	「antitumor」「anti-tumor」「制癌性」「抗癌」「抗がん」
拡張検索	「anticancer drug」「anticancer effect」

「antitumor」

　　[★]

• 抗腫瘍性の、抗腫瘍の、制癌性の、制癌の

関

anti-tumor、anticancer、antitumoral、antitumorigenic、antitumour、carcinostatic

「anti-tumor」

　　[★]

• 抗腫瘍の、制癌の、抗腫瘍性の、制癌性の

関

anticancer、antitumor、antitumoral、antitumorigenic、antitumour、carcinostatic

「制癌性」

　　[★]

英

antitumor、anti-tumor、anticancer

関

抗がん、抗癌、抗癌性、抗腫瘍、抗腫瘍性、制癌

「抗癌」

　　[★]

英

anticancer、anticarcinogenic

関

抗がん、抗癌性、抗腫瘍形成、制癌性

「抗がん」

　　[★]

英

anticancer、anticarcinogenic

関

抗癌、抗癌性、抗腫瘍形成、制癌性

「anticancer drug」

　　[★]

• 抗癌剤、抗癌薬

関

anticancer agent、anticarcinogenic agent

「anticancer effect」

　　[★]

• 制癌効果、制癌作用